SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease
6 references·0 citing·23 second hop
Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease (2022)Cost-Effectiveness of Dapagliflozin as a …Introduction to the Special Issue on "The World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) Update" (2021)Introduction to the Special I…Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany (2018)Health Care Costs Associated …The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84) (2014)The impact of diabetes‐relate…Review of Utility Values for Economic Modeling in Type 2 Diabetes (2014)Review of Utility Values for …Spanish recommendations on economic evaluation of health technologies (2010)Spanish recommendations on ec…International study of health care organization and financing: development of renal replacement therapy in Germany (2007)International study of health…A Comparison of Alternative Models for the Demand for Medical Care (1983)The impact of diabetes‐related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65) (2003)Societal costs of diabetes mellitus in Denmark (2015)Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up (2020)A study of the quality of life and cost-utility of renal transplantation (1996)Modeling Valuations for EuroQol Health States (1997)US Valuation of the EQ-5D Health States (2005)Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study (2015)“Stay at Home, Protect the National Health Service, Save Lives”: A cost benefit analysis of the lockdown in the United Kingdom (2020)The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review (2020)A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) (2004)Review of statistical methods for analysing healthcare resources and costs (2010)The Economic Costs of Type 2 Diabetes: A Global Systematic Review (2015)Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses (2020)Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden (2020)Generalized cost-effectiveness analysis for national-level priority-setting in the health sector (2003)Making fair choices on the path to universal health coverage (2014)Ethical priority setting for universal health coverage: challenges in deciding upon fair distribution of health services (2016)Methods for the Economic Evaluation of Health Care Interventions for Priority Setting in the Health System: An Update From WHO CHOICE (2021)Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report (2016)Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report (2017)Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare (2018)End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF) (2007)
this work references cited by second hop

References

  • 2014Review of Utility Values for Economic Modeling in Type 2 Diabetes256 cited
  • 2010Spanish recommendations on economic evaluation of health technologies240 cited
  • 2014The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84)192 cited
  • 2018Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany141 cited
  • 2021Introduction to the Special Issue on "The World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) Update"91 cited
  • 2007International study of health care organization and financing: development of renal replacement therapy in Germany43 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work